AJU IB Investment Co., Ltd.
Seoul, M5 · CIK 1710065 · 13F filing filed 2021-08-10
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Kindventure
- Others nearbySan Francisco, CA, Boston, MA, Seoul
- FamilyAJU IB Investment Co., Ltd. · 3 related pages
$173.4m
reported value
-34.6% vs Q1 2021
11positions
100.0%in top 10
0 new
0 added
5 reduced
0 sold out
vs Q1 2021
Holdings, Q2 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APELLIS PHARMACEUTICALS INC APLS | $67.3m38.81% | Reduced -50.0k |
| ATEA PHARMACEUTICALS INC AVIR | $37.5m21.62% | Reduced -304.0k |
| KYMERA THERAPEUTICS INC KYMR | $31.0m17.87% | Unchanged |
| SEER INC SEER | $26.8m15.43% | Reduced -250.0k |
| SUTRO BIOPHARMA INC COM | $3.3m1.88% | Unchanged |
| RAPT THERAPEUTICS INC COM | $3.2m1.82% | Reduced -9.0k |
| MOLECULAR TEMPLATES INC COM | $1.6m0.92% | Unchanged |
| CLEARSIDE BIOMEDICAL INC COM | $1.4m0.82% | Reduced -500.0k |
| KEZAR LIFE SCIENCES INC COM | $700.0k0.40% | Unchanged |
| AILERON THERAPEUTICS INC ALRN | $647.0k0.37% | Unchanged |
| BELLICUM PHARMACEUTICALS INC BLCM | $85.0k0.05% | Unchanged |